Hanmi plans to make public anti-obesity drug

Hanmi Pharm said recently that it plans to release a new drug to treat obesity in the latter half of this year.

However, the exact launching date for the anti-obesity Slimmer (sibutramine mesylate) has yet to be set, pending approval from the nation's food and drug watchdog, company officials said.

Hanmi had to postpone its original release date from this month when the Korea Food and Dru...